Literature DB >> 6101209

Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes.

J V Ravetch1, U Siebenlist, S Korsmeyer, T Waldmann, P Leder.   

Abstract

The variable portion of an immunoglobulin heavy chain gene is assembled from at least three discontinuous segments of DNA, the V, D and J regions. We have characterized a 30 kb segment of the human genome that plays a critical role in the formation of this variable region as well as in the expression of the two heavy chains that appear earliest in immunocyte ontogeny, the mu and delta chains. This region encodes nine J-like segments, an interspersed D segment, recombination signals and the genes responsible for the production of both mu and delta heavy chains. Six of the nine germline J-like genes appear to be active and easily account for most of the known human heavy chain amino acid sequences. Three of the J-like genes are pseudogenes. The large number of human J region genes and, hence, their greater potential for generating diversity as compared to the that of the mouse J region genes appears to result from recent genetic duplications. To assess this potential, we have analyzed two recombinant genes involving this region. One of these, a V-D-J recombinant, is likely to be an active gene; the other, an aberrant D-J recombinant. A comparison of the structures of these D regions raises the possibility that they are mosaics formed by recombination between D segments.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6101209     DOI: 10.1016/0092-8674(81)90400-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  245 in total

1.  Superantigens and autoantigens may be involved in the pathogenesis of gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  T Hashimoto; M Takishita; M Kosaka; T Sano; T Matsumoto
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

2.  Clonal evolution of B cells in transformation from low- to high-grade lymphoma.

Authors:  A Matolcsy; E J Schattner; D M Knowles; P Casali
Journal:  Eur J Immunol       Date:  1999-04       Impact factor: 5.532

3.  Molecular genetic analysis of lymphoid tumors arising after organ transplantation.

Authors:  J Locker; M Nalesnik
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

4.  Molecular characterization of ataxia telangiectasia T cell clones. III. Mapping the 14q32.1 distal breakpoint.

Authors:  M H Stern; F R Zhang; G Thomas; C Griscelli; A Aurias
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

5.  Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning.

Authors:  Thomas Tiller; Eric Meffre; Sergey Yurasov; Makoto Tsuiji; Michel C Nussenzweig; Hedda Wardemann
Journal:  J Immunol Methods       Date:  2007-10-31       Impact factor: 2.303

6.  Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.

Authors:  M L Cleary; J Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

7.  Immunoglobulin mu-chain gene rearrangement in a patient with T cell acute lymphoblastic leukemia.

Authors:  K Ha; M Minden; N Hozumi; E W Gelfand
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  Human small-cell lung cancers show amplification and expression of the N-myc gene.

Authors:  M M Nau; B J Brooks; D N Carney; A F Gazdar; J F Battey; E A Sausville; J D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

9.  Evolution of immunoglobulin genes: VH families in the amphibian Xenopus.

Authors:  E Hsu; J Schwager; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors.

Authors:  L Mantovani; R L Wilder; P Casali
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.